Status:

COMPLETED

Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

Lead Sponsor:

XuanwuH 2

Conditions:

Cerebral Infarction

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

Human urinary kallidinogenase can promote the establishment of collateral circulation in the ischemic penumbra due to the stenosis or occlusion of middle cerebral artery and then increase the perfusio...

Detailed Description

Patients with acute ischemic stroke will be given human urinary kallidinogenase .Then we will estimate the cerebral collateral circulation in ischemic regions and final infarct volume, comparing with ...

Eligibility Criteria

Inclusion

  • Age:greater than or equal to 18 years old and less than or equal to 70 years old;
  • Time of onset is less than 7 days;
  • Acute cerebral infarction due to the stenosis or occlusion of middle cerebral artery diagnosed by CT or MRI;
  • The National Institute of Health Stroke Scale(NIHSS) score is 4 to 20;
  • Excluding intracranial hemorrhage using CT or MRI.

Exclusion

  • The NIHSS score is less than or equal to 3;
  • Patients with cerebral aneurysm, cerebral hemorrhage, brain tumor, brain contusion and laceration of brain and other diseases;
  • Intracranial hemorrhage displaying by CT or MRI; Cardiac insufficiency;
  • Cardiac insufficiency;
  • Chronic liver disease(A/G inversion),elevated alanine aminotransferase(ALT)(more than 1.5 times the normal value);
  • Increased serum creatinine(more than 1.5 times the normal value);
  • Poorly controlled diabetes;
  • Recently suffered from hemorrhagic disease or bleeding tendency;
  • Recent use of angiotensin-converting enzyme inhibitor (ACEI) drugs;
  • Allergic constitution and had a variety of drug allergy history;
  • Women in period of pregnancy or lactation.

Key Trial Info

Start Date :

January 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT02259738

Start Date

January 1 2013

End Date

June 1 2014

Last Update

October 8 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Neurolgy,Xuanwu Hospital of Capital Medical University

Beijing, Beijing Municipality, China, 100053